Home
Scholarly Works
A phase II study of sunitinib in recurrent or...
Conference

A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the Princess Margaret Hospital, The University of Chicago, and California Cancer Phase II Consortia

Authors

Correa R; Mackay H; Hirte HW; Morgan R; Welch S; Fleming GF; Wang L; Blattier C; Ivy SP; Oza AM

Volume

28

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2010

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team